Lung-cancer-blog.comLung-cancer-blog.comLung cancer is the second most common cancer for all males and females in the United States.
Articles:
1, 2
Articles
Avastin approved in Europe for advanced lung cancer
2007-09-15 00:00:00 Roche's innovative anti-cancer drug, was approved today in Europe for the first-line therapy of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy. NSCLC is the most common form of lung cancer, a difficult to treat disease that kills over 3,000 people per day worldwide. NSCLC is commonly diagnosed at an advanced stage, meaning individuals diagnosed with the disease typically have a life expectancy of only 8 to 10 months. Avastin is the only first-line treatment to demonstrate improved survival benefits beyond one year in patients with advanced NSCLC........ More About: Cancer , Lung Cancer , Vast , Prove
Radiation and drug combo for lung cancer
2007-09-15 00:00:00 Combining radiation treatment with a drug that helps destroy blood vessels nourishing cancerous tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, scientists at UT Southwestern Medical Center have found. The study, involving human lung-cancer cells implanted in mice, appears in the Sept. 1 issue of Clinical Cancer Research........ More About: Lung Cancer , Drug , Radiation , Combo
Smoking may interfere with alcoholics' neurocognitive recovery
2007-09-15 00:00:00 Alcoholics frequently smoke. Anywhere from 50 to 90 percent of individuals in North America who seek alcoholism therapy are also chronic smokers. New findings indicate that smoking may interfere with alcoholics neurocognitive recovery during their first six to nine months of abstinence from alcohol........ More About: Recovery , Smoking
Talcum powder stunts growth of lung tumors
2007-09-15 00:00:00 Talcum powder has been used for generations to soothe babies diaper rash and freshen womens faces. But University of Florida researchers report the household product has an additional healing power: The ability to stunt cancer growth by cutting the flow of blood to metastatic lung tumors. The study, published in the European Respiratory Journal in April, reveals that talc stimulates healthy cells to produce endostatin, a hormone considered the magic bullet for treating metastatic lung cancer. The UF researchers say talc is an exciting new therapeutic agent for a cancer largely considered incurable........ More About: Growth , Grow , Stunts
Advances In Lung Cancer Treatment
2007-09-15 00:00:00 Scientists at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents. Led by Balazs Halmos, MD, hematologist/oncologist with the Ireland Cancer Center, the research team followed up on their prior study, reported in the New England Journal (NEJM), which observed that lung cancer cells can become resistant to novel targeted agents, such as Tarceva (erlotinib), a medicine in widespread use for non-small-cell lung cancer (NSCLC). Tarceva is among a new generation of cancer therapies that disrupt the molecular target responsible for stimulating tumor growth. The drug targets the receptor for the epidermal growth factor protein (EGFR) to halt the spread of cancer cells. Clinical applications of the new drug initially yielded good results with approximately 10 percent of patients experiencing complete remission of their disease........ More About: Treatment , Cancer treatment , Lung Cancer , Vance
Secondhand smoke proves to be serious
2007-09-15 00:00:00 A study published in this months issue of the Journal of Periodontology found that subjects with periodontitis who were exposed to secondhand smoke were more likely to develop bone loss, the number one cause of tooth loss. Researchers studied rats that were induced with periodontal disease. One group was not exposed to cigarette smoke while the other two groups were exposed to either 30 days of smoke inhalation produced by non-light cigarettes (cigarettes containing higher tar, nicotine and carbon monoxide levels) or light cigarettes (cigarettes containing lower tar, nicotine and carbon monoxide levels). Results showed that bone loss was greater in the subjects exposed to secondhand smoke regardless of if it was smoke from light or non-light cigarettes than those who were exposed to no smoke at all........ More About: Smoke , Prove
Race affects tobacco absorption in children
2007-09-15 00:00:00 New research suggests that a child's race may be a factor in determining his/her susceptibility to tobacco toxins linked to environmental tobacco smoke (ETS). The study, reported in the recent issue of CHEST, the peer-evaluated journal of the American College of Chest Physicians (ACCP), reveals that African American children with asthma, who are exposed to ETS, have significantly higher toxin levels when in comparison to their Caucasian counterparts........ More About: Children , Race , Tobacco , Absorption
New Cigarettes Designs Don't Offer Lower Cancer Risks
2007-09-15 00:00:00 The tobacco company's description of its new cigarette brand seems to promise a lot. "May present less risk of cancer linked to smoking," the company boasts on its Web site, making it a natural choice "for smokers who have decided not to quit, but who are interested in a cigarette that responds to concerns about certain smoking-related illnesses, including cancer." Another tobacco firm, in a print ad for the brand, has crowed "All of the taste. Less of the toxins"........ More About: Cancer , Cigarettes , Lower , Cigarette , Designs
Smoking Greatly Increases The Risk For Lung Cancer
2007-09-15 00:00:00 Lung cancer is the most deadly of all cancers. It is the leading cause of cancer death for both men and women, as per the American Cancer society (ACS). More people die of this than of colon, breast, and prostate cancers combined. The ACS predicts that in 2007 there will be about 213,380 new cases. Of this number, about 160,390 people will die........ More About: Smoking , Lung Cancer , Risk
Lack Of A Protein In Lung Tumors
2007-09-15 00:00:00 A study of human lung tumors indicates that patients with lung cancer who lack a particular protein may do more poorly than those with normal levels of that same protein. If the findings are verified in a clinical trial, the absence of the protein might be used to identify patients with lung cancer who need more aggressive treatment after surgery........ More About: Protein , Prot , Lack
Genetics of smoking cessation
More articles from this author:2007-09-15 00:00:00 A genetic variant present in nearly half of Americans of European ancestry is associated with greater effectiveness of the smoking cessation medicine bupropion (Zyban), as per research by researchers supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). People with this variant were less likely than those without it to have resumed smoking six months after therapy with bupropion........ More About: Smoking , Genetics 1, 2 |
 |
|
 |
